Helius Medical Technologies Inc is trading 5.1% down today at $1.66 as investors reassess the company's standalone prospects after it rejected an all-stock acquisition proposal from Forward Industries.
- The board of directors declined the offer, which valued shares in the mid-$1 range, stating that it significantly undervalued the company.
- While the stock initially rallied after the June 16 disclosure, traders are now weighing the implications of the rejection against a mixed broader market environment.